Article 3

Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance · European Union

A clinical trial may be conducted only if: the rights, safety, dignity and well-being of subjects are protected and prevail over all other interests; and it is designed to generate reliable and robust data.

← art_2__para_3__text_1 · All articles · art_3__text_1 →

Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.